Flu Vaccines and Associated Supplies
Department of Defense (all) · NATL GEOSPATIAL-INTELLIGENCE AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HM047626Q0030 in this department, oldest first.
- Jul 29, 2026 · this noticeCombined Synopsis/Solicitation
- Jul 31, 2026Combined Synopsis/SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Please review the solicitation document HM047626Q0030 and Statement of Work (SOW) and fill in the attached quote sheet. The Government will award a single contract resulting from this solicitation to the responsible offeror whose quote conforms to the solicitation requirements and represents the Lowest Price Technically Acceptable (LPTA) baseline.
Who won similar work
35 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Department of Defense (all)), same product/service code (PSC) 6505.
Single-winner award sizes (35): middle half $723K to $11.1M, median $3.2M; range $52K to $133.2M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Golden State Medical Supply, Inc. | 8 | $202.2M | Oct 14, 2026 |
| CARDINAL HEALTH 414, LLC · $CAH · $226.8B | 4 | $8.3M | Oct 1, 2026 |
| AVKARE LLC | 2 | $13.7M | Sep 1, 2026 |
| SpecGx, LLC | 2 | $13.2M | Sep 9, 2026 |
| SANOFI PASTEUR INC. | 1 | $25.1M | Apr 25, 2025 |
| Exelan Pharmaceuticals Inc. | 1 | $24.1M | Jun 13, 2025 |
| RADHA PHARMACEUTICALS INC | 1 | $23.3M | Sep 14, 2026 |
| Bayer HealthCare Pharmaceuticals Inc | 1 | $10.3M | Jun 3, 2026 |
| SEQIRUS USA INC | 1 | $6.9M | Apr 25, 2025 |
| PURACAP LABORATORIES LLC | 1 | $6.4M | Jun 9, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $CAH reported $226.8B revenue in FY2026. The median single-winner award in these 35 past awards, $3.2M, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 14, 2026Golden State Medical Supply, Inc.$15.3MPravastatin SolicitationNo listed company matched (Materiality N/A)
- Oct 7, 2026GOLDEN STATE MEDICAL SUPPLY INC$4.3MQuetiapine Fumarate XR TabletsNo listed company matched (Materiality N/A)
- Oct 6, 2026AGILENT TECHNOLOGIES INC$350KIHC Reagents and SuppliesMateriality: <0.01% of $A revenue (Low) SEC
- Oct 1, 2026CARDINAL HEALTH 414, LLC$2.4MFDA-Approved Radiopharmaceutical Supplies and Cold KitsMateriality: <0.01% of $CAH revenue (Low) SEC
- Sep 24, 2026GOLDEN STATE MEDICAL SUPPLY INC$17.6MOlopatadine HCL 0.1% Ophthalmic SolutionNo listed company matched (Materiality N/A)
- Sep 14, 2026RADHA PHARMACEUTICALS INC$23.3MBupropion HCL ERNo listed company matched (Materiality N/A)
- Sep 9, 2026SpecGx, LLC$5.9MMethylphenidate HCL IRNo listed company matched (Materiality N/A)
- Sep 3, 2026GOLDEN STATE MEDICAL SUPPLY, INC.$2.4MSolifenacin AwardNo listed company matched (Materiality N/A)
- Sep 2, 2026SPECGX LLC$7.3MOxycodone HCL-Acetaminophen TabletsNo listed company matched (Materiality N/A)
- Sep 1, 2026AVKARE LLC$11.9MAnastrozole - AwardNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (4 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- $46K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.